Twist Bioscience Corporation (TWST)
Twist Bioscience Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Twist Bioscience Corporation (TWST) is a Medical - Diagnostics & Research company based in US with a market capitalization of $4.3B. Revenue grew 20.3% year-over-year and free cash flow was negative at -$75.6M. This page tracks TWST's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 923 employees · IPO Oct 31, 2018
Valuation
Valuation & price
$49.17as of May 17, 2026· -52.2% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
9.10
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$4.3B
Market cap
20.3%
Revenue growth (YoY)
50.7%
Gross margin
-$75.6M
Free cash flow (USD)
-$95.1M
Net debt
Net cash position
3.1%
Share dilution
1/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
5
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 4, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- Insider sellJun 26, 2026Filing
Insider Sell $1.8M · 10b5-1 PlanLeproust Emily M. · Director, Chief Executive Officer · $1.8M
- Insider sellJun 26, 2026Filing
Insider Sell $1.3M · 10b5-1 PlanCho Dennis · See Remarks · $1.3M
- Insider sellJun 24, 2026Filing
Insider Sell $147KLeproust Emily M. · Director, Chief Executive Officer · $147.4K
- Insider sellJun 24, 2026Filing
Insider Sell $30KCho Dennis · See Remarks · $30.2K
- Insider sellJun 24, 2026Filing
Insider Sell $25KGreen Paula · SVP of Human Resources · $25.4K
- FinancingJun 18, 2026Filing
Securities Registration
- 8-K eventMay 4, 2026Filing
Earnings Release
- Quarterly reportMay 4, 2026Filing
10-Q Filed
Questions
Frequently asked questions
What is Twist Bioscience Corporation's market cap?
Twist Bioscience Corporation (TWST) has a market capitalization of $4.3B.
What is TWST's P/E ratio?
A meaningful P/E ratio is not available for TWST — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is TWST's price-to-book (P/B) ratio?
TWST trades at 9.10 times book value per share.
Are insiders buying TWST stock?
SEC Form 4 filings show no open-market insider buys at Twist Bioscience Corporation in the last 90 days (5 sells).
Same arena
Related companies in Medical - Diagnostics & Research
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.